Tocqueville Asset Management L.P. Purchases 111,937 Shares of Revvity, Inc. (NYSE:RVTY)

Tocqueville Asset Management L.P. grew its position in Revvity, Inc. (NYSE:RVTY) by 91.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 234,625 shares of the company’s stock after purchasing an additional 111,937 shares during the quarter. Tocqueville Asset Management L.P. owned approximately 0.19% of Revvity worth $26,186,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. Victory Capital Management Inc. increased its holdings in Revvity by 4.5% in the third quarter. Victory Capital Management Inc. now owns 59,860 shares of the company’s stock worth $7,647,000 after purchasing an additional 2,582 shares in the last quarter. Metis Global Partners LLC grew its position in shares of Revvity by 6.5% during the 3rd quarter. Metis Global Partners LLC now owns 7,825 shares of the company’s stock worth $1,000,000 after buying an additional 481 shares during the period. CIBC Asset Management Inc increased its stake in shares of Revvity by 8.2% in the 3rd quarter. CIBC Asset Management Inc now owns 17,993 shares of the company’s stock valued at $2,299,000 after acquiring an additional 1,368 shares in the last quarter. Empirical Finance LLC lifted its position in shares of Revvity by 2.0% during the 3rd quarter. Empirical Finance LLC now owns 4,237 shares of the company’s stock valued at $541,000 after acquiring an additional 85 shares during the period. Finally, Empowered Funds LLC bought a new position in Revvity during the third quarter worth $227,000. Institutional investors own 86.65% of the company’s stock.

Insider Activity

In other news, insider Tajinder S. Vohra sold 5,492 shares of the firm’s stock in a transaction that occurred on Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the completion of the sale, the insider now owns 19,652 shares in the company, valued at $2,295,550.12. This trade represents a 21.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Joel S. Goldberg sold 15,170 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the transaction, the insider now owns 33,400 shares in the company, valued at approximately $4,232,782. The trade was a 31.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on RVTY shares. Sanford C. Bernstein downgraded shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target for the company. in a research note on Friday, January 10th. Raymond James reaffirmed an “outperform” rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. KeyCorp increased their price target on Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Bank of America upgraded Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price objective for the company in a report on Friday, December 13th. Finally, Barclays increased their target price on Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Four equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $136.25.

Revvity Stock Performance

NYSE RVTY opened at $113.30 on Tuesday. The company has a fifty day moving average price of $116.97 and a 200-day moving average price of $117.86. The firm has a market cap of $13.61 billion, a price-to-earnings ratio of 51.27, a PEG ratio of 3.82 and a beta of 1.06. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. Revvity, Inc. has a 1 year low of $97.32 and a 1 year high of $129.50.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period in the prior year, the business posted $1.25 earnings per share. As a group, equities research analysts predict that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be given a $0.07 dividend. The ex-dividend date is Thursday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.25%. Revvity’s dividend payout ratio is currently 12.67%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.